rs876540

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_194318.4(B3GLCT):​c.*1644A>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.107 in 152,128 control chromosomes in the GnomAD database, including 1,633 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1633 hom., cov: 31)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

B3GLCT
NM_194318.4 3_prime_UTR

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.13

Publications

6 publications found
Variant links:
Genes affected
B3GLCT (HGNC:20207): (beta 3-glucosyltransferase) The protein encoded by this gene is a beta-1,3-glucosyltransferase that transfers glucose to O-linked fucosylglycans on thrombospondin type-1 repeats (TSRs) of several proteins. The encoded protein is a type II membrane protein. Defects in this gene are a cause of Peters-plus syndrome (PPS).[provided by RefSeq, Mar 2009]
B3GLCT Gene-Disease associations (from GenCC):
  • Peters plus syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_194318.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 13-31331312-A-T is Benign according to our data. Variant chr13-31331312-A-T is described in ClinVar as Benign. ClinVar VariationId is 883166.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.396 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_194318.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
B3GLCT
NM_194318.4
MANE Select
c.*1644A>T
3_prime_UTR
Exon 15 of 15NP_919299.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
B3GLCT
ENST00000343307.5
TSL:1 MANE Select
c.*1644A>T
3_prime_UTR
Exon 15 of 15ENSP00000343002.4Q6Y288
B3GLCT
ENST00000873566.1
c.*1644A>T
3_prime_UTR
Exon 13 of 13ENSP00000543625.1

Frequencies

GnomAD3 genomes
AF:
0.106
AC:
16186
AN:
152010
Hom.:
1627
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.215
Gnomad AMI
AF:
0.0241
Gnomad AMR
AF:
0.102
Gnomad ASJ
AF:
0.0784
Gnomad EAS
AF:
0.411
Gnomad SAS
AF:
0.180
Gnomad FIN
AF:
0.0344
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0274
Gnomad OTH
AF:
0.100
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
10
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
10
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
10
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.107
AC:
16232
AN:
152128
Hom.:
1633
Cov.:
31
AF XY:
0.110
AC XY:
8217
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.215
AC:
8925
AN:
41458
American (AMR)
AF:
0.102
AC:
1555
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.0784
AC:
272
AN:
3470
East Asian (EAS)
AF:
0.411
AC:
2124
AN:
5170
South Asian (SAS)
AF:
0.180
AC:
870
AN:
4826
European-Finnish (FIN)
AF:
0.0344
AC:
364
AN:
10590
Middle Eastern (MID)
AF:
0.0714
AC:
21
AN:
294
European-Non Finnish (NFE)
AF:
0.0274
AC:
1862
AN:
68022
Other (OTH)
AF:
0.103
AC:
217
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
658
1316
1974
2632
3290
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
190
380
570
760
950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0539
Hom.:
381
Bravo
AF:
0.117
Asia WGS
AF:
0.280
AC:
971
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
-
-
1
Peters plus syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.13
DANN
Benign
0.51
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs876540;
hg19: chr13-31905449;
COSMIC: COSV58455185;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.